New Kinase Inhibitor Effective against Drug-Resistant Leukemia, Preclinical Study Finds
March 21, 2016 By Laura Oleniacz, UNC Lineberger Comprehensive Cancer Center Read the entire article here .
March 21, 2016 By Laura Oleniacz, UNC Lineberger Comprehensive Cancer Center Read the entire article here .
Story by Susan Hudson, University Gazette Video by Carly Swain, Office of Communications and Public Affairs Published March 30, 2016 Read the article in its entirety here. http://www.unc.edu/spotlight/pharmacy-school-celebrates-top-ranking/
Dr. Sarah Scarry was appointed to the position of Research Assistant Professor in the Division of Chemical Biology and Medicinal Chemistry in the UNC Eshelman School of Pharmacy. Dr. Scarry will be expanding her medicinal chemistry expertise into the arena … Read more
On March 16, 2016, Dave Etchison writes, “The UNC Eshelman School of Pharmacy is number one in the latest rankings by U.S. News & World Report of the nation’s Doctor of Pharmacy programs in the 2017 edition of “America’s Best … Read more
February 16, 2016 an IND was opened for clinical trials of MRX2843 (UNC2371) in patients with solid tumors. On March 1, 2016 a patent was issued for UNC2371 (MRX2843 as licensed to Meryx Inc., http://meryxpharma.com/home). The inventors Xiaodong Wang, Jing … Read more
Using New Screening Tool, UNC Researchers Identify Potential Treatments for Ewing Sarcoma March 1, 2016 By Laura Oleniacz, UNC Lineberger Comprehensive Cancer Center Stephen Frye, Ph.D., directs the School’s drug discovery center, which played a key role in the recent … Read more